Red Blood Cells are appropriate carrier for coagulation factor VIII.
CONCLUSION: This study aims to introduce erythrocytes as appropriate carriers for FVIII to prolong the dosing intervals in the effective and safe levels for a relatively longer time.
PMID: 31533604 [PubMed - as supplied by publisher]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research
More News: Cardiology | Cardiovascular | Dialysis | Drugs & Pharmacology | Haemophilia | Heart | Hematology | Hemophilia | Study